Additional file 3 of Pharmacokinetics, efficacy and tolerance of cefoxitin in the treatment of cefoxitin-susceptible extended-spectrum beta-lactamase producing Enterobacterales infections in critically ill patients: a retrospective single-center study

Chabert, Paul; Provoost, Judith; Cohen, Sabine; Dupieux-Chabert, Céline; Bitker, Laurent; Ferry, Tristan; Goutelle, Sylvain; Richard, Jean-Christophe

doi:10.6084/m9.figshare.21251557.v1

13613_2022_1059_MOESM3_ESM.pdf (128.03 kB)

Additional file 3 of Pharmacokinetics, efficacy and tolerance of cefoxitin in the treatment of cefoxitin-susceptible extended-spectrum beta-lactamase producing Enterobacterales infections in critically ill patients: a retrospective single-center study

journal contribution

posted on 2022-09-30, 06:15 authored by Paul Chabert, Judith Provoost, Sabine Cohen, Céline Dupieux-Chabert, Laurent Bitker, Tristan Ferry, Sylvain Goutelle, Jean-Christophe Richard

Additional file 3: Figure S1. Model prediction versus observed cefoxitin concentrations.

History

Usage metrics

Keywords

Antibacterial chemotherapy Intensive care Healthcare-associated pneumonia Extended-spectrum beta-lactamase Carbapenem-sparing agents Cefoxitin Population pharmacokinetics

Licence

CC BY

Exports

RefWorks

BibTeX

Ref. manager

Endnote

DataCite

NLM

DC

Additional file 3 of Pharmacokinetics, efficacy and tolerance of cefoxitin in the treatment of cefoxitin-susceptible extended-spectrum beta-lactamase producing Enterobacterales infections in critically ill patients: a retrospective single-center study

History

Usage metrics

Categories

Keywords

Licence

Exports